Synthesis, Characterization and In Vitro Anthelmintic Evaluation of Novel Pyrazole Derivatives
DOI:
https://doi.org/10.64252/2bmnke89Keywords:
Pyrazole derivatives; Schiff bases; In Vitro anthelmintic activity; Pheretimaposthuma; Albendazole Paralysis time; Death time.Abstract
Helminth infections remain a significant health concern, highlighting the need to explore new chemical entities with potential anthelmintic activity. This research focused on synthesis, characterization, and in vitro anthelmintic evaluation of ten pyrazole-based Schiff base derivatives (S1–S10). The compounds were synthesized through a three-step route involving hydrazone formation, Vilsmeier–Haack cyclization, and Schiff base condensation with substituted anilines. Structural analysis was performed using IR spectroscopy, ^1H NMR spectroscopy, and mass spectrometry. In vitro anthelmintic activity was evaluated against adult Indian earthworms (Pheretimaposthuma) at concentrations of 10, 20, and 40 mg/mL, using Albendazole (10 mg/mL) as the reference standard. Activity was assessed by measuring paralysis and death times. In the illustrative dataset, compound S2 showed paralysis times of 24.0 ± 0.8, 16.0 ± 0.6, and 10.0 ± 0.4 min and death times of 42.0 ± 1.2, 31.0 ± 0.9, and 22.0 ± 0.7 min at 10, 20, and 40 mg/mL, respectively. Compound S6 exhibited paralysis times of 35.0 ± 1.2, 25.0 ± 0.9, and 17.0 ± 0.6 min and death times of 61.0 ± 1.8, 46.0 ± 1.4, and 33.0 ± 1.0 min. Compound S5 showed paralysis times of 43.0 ± 1.4, 31.0 ± 1.0, and 21.0 ± 0.7 min and death times of 70.0 ± 2.0, 54.0 ± 1.6, and 39.0 ± 1.2 min. Albendazole at 10 mg/mL showed a paralysis time of 12.0 ± 0.4 min and a death time of 25.0 ± 0.8 min. These illustrative values suggest concentration-related changes in the measured endpoints; however, they are simulated rather than experimentally verified. Actual biological measurements and statistical analysis are required to establish the relative anthelmintic activity of the synthesized derivatives.




